Ashapura Minechem Ltd
ASHAPURMINAshapura Minechem Ltd's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it.
The sharpest disagreement: annual EPS moved +35.7% against a −10.7% price move — the market has not yet caught up with the delivery.
The price is in a confirmed uptrend (16 weeks in) while the P/E sits at the 37th percentile of its own 11-year range. Underneath, the last four quarters read deteriorating — profit −5.3% year on year, and 81% of the last 3 years' profit arrived as cash. What settles it: whether the price catches up with earnings that have already moved.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Ashapura Minechem Ltd trades at ₹543, in a confirmed uptrend and 16 weeks into that stage. That is −13.0% against its own 200-day average. It sits at 13% of a 52-week range of ₹487 to ₹901. On relative strength it is currently behind the NIFTY 500 on a trailing-13-week view (11 weeks and counting).
Today the stock is in a confirmed uptrend — week 16 of stage 2. At ₹543 it trades −13.0% versus its 200-day average and sits at 13% of its 52-week range (₹487–₹901).
Against the market, two honest reads. Cumulative: over the last 10.5 years the stock moved +594% while the NIFTY 500 moved +267% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (11 weeks and counting; last ahead the week of 2026-07-01) — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.
Ashapura Minechem Ltd trades at 12.6× P/E, mid-range by its own standards (37th percentile). Its long-run median P/E is 14.2×, measured across 10.5 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 12.6× is mid-range by its own standards (37th percentile), against a long-run median of 14.2× measured over 10.5 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
Why the multiple sits where it does: over the past year annual EPS moved +35.7% against a −10.7% price move — earnings outran the price, pushing the multiple DOWN its own range.
The price move, decomposed: over 5y, of the +30.8%/yr price move, ~+27.5%/yr came from earnings growth and ~+3.3 pp from the multiple (expanding); over 10y, of the +24.3%/yr price move, ~+13.6%/yr came from earnings growth and ~+10.7 pp from the multiple (expanding). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is unremarkable against its own past, so the story rests on the earnings line underneath it, not the multiple.
A quarterly PEG curve, which only the second data source carries, is not drawn on this page: its two data sources disagree by up to 16% on reported income across 14 comparable periods. A figure two sources cannot agree on is not drawn — the gap is a decision, not missing data.
What the price assumes This reading works the multiple backwards. It asks one question: what yearly rate of profit growth is a buyer at the market price already paying for? The number is the growth rate that makes eleven years of profit — six years growing, then five fading — add up to that day's market price, once each year is discounted at 11% a year.
Solved at its 13 June 2026 price, Ashapura Minechem Ltd was paying for profit growth of about 6.3% a year. Profit itself has compounded 9.9% a year over the past 10 years. Today the market pays 12.6× P/E, the 37th percentile of its own 11-year range.
What the two numbers say together. The multiple is unremarkable against its own past, and the growth the price is paying for is close to what this company has actually delivered.
How to hold this number: it is a reading of one day's price, taken on 13 June 2026, not a running figure — every other number on this page, the multiple included, is read off the live quote as of 11 September 2026. A higher price is paying for more growth and a lower price for less, so it moves whenever the price does, and this page does not restate it between measurements.
Stage: Mixed Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Ashapura Minechem Ltd reads as mixed on its fundamental arc. Mixed — growth is normalizing off a hyper-growth base: profit growth has eased from +43.9% at its peak to +19.5% but is still expanding, ROCE lifting at 21.0%. The read is built from 8 quarters across 4 curves, on partial evidence.
Why it matters: when the curves disagree, the per-curve reads above matter more than any single verdict.
Return readings here are annual, not quarterly — read as level and direction only; they can confirm the growth curves but never drive the stage on their own.
A partial read: at least one curve is short, or the returns curve is not the computed quarterly series — hold the stage word a little more loosely.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +91.2% | +41.9% | +35.5% | +11.4% |
| Profit | +43.9% | +55.8% | +36.7% | +9.9% |
| EPS | +35.7% | +48.7% | +33.1% | +8.5% |
| Share price | −10.7% | +24.0% | +30.8% | +24.3% |
4-Factor Sector Score
55.1/100 — rank 3 of 13 in Mining/Minerals · 76% evidence confidence
Ashapura Minechem Ltd scores 55.1 out of 100 against the 13 companies it is compared with in Mining/Minerals, ranking 3. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
The four contributions add to the total exactly: 20.2 + 18 + 11.5 + 5.4 = 55.1. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
Ashapura Minechem Ltd reported ₹1,616 Cr of revenue in the Jun 26 quarter, +19.2% year on year. That is the 8th straight quarter of year-on-year growth. Over 10 years it has compounded at 11.4% a year. The last full year, FY26, came in at ₹5,237 Cr. The last four reported quarters add to ₹5,497 Cr.
FY26 revenue came in at ₹5,237 Cr (+91.2% on the year), capping 10 years at 11.4% compound. The latest quarter (Jun 26) printed ₹1,616 Cr, +19.2% year on year — the 8th consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +85.6% growth against the decade's 11.4% — the current year is running faster than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +62.6% over the last 4 quarters against +50.7%/yr over the last 8 — accelerating; TTM profit +19.5% vs +31.1%/yr — rolling over.
Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
Ashapura Minechem Ltd's operating margin is 11.0% in the Jun 26 quarter, −2.0 percentage points against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged −14.0% to 22.0%. The current quarter sits inside that band.
The latest quarter's operating margin is 11.0%, −2.0 pp against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged −14.0%–22.0%.
🚨 Why the margin moved: operating margin went −2.2 pp year on year while gross margin went +5.8 pp — the loss came mostly from the gross line: input costs and pricing.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Ashapura Minechem Ltd earned ₹108 Cr of net profit in the Jun 26 quarter, −5.3% year on year. Full-year FY26 profit was ₹416 Cr. The 10-year compound rate is 9.9%. That is 6.7% of the quarter's revenue. The same quarter a year earlier earned ₹114 Cr.
Jun 26 profit was ₹108 Cr, −5.3% year on year. On the full year, FY26 printed ₹416 Cr (+43.9%), and the 10-year compound rate is 9.9%.
🚨 Why profit moved: revenue contributed +19.2% and the margin −2.0 pp — the quarter was revenue-led despite a thinner margin.
Pace comparison, last four quarters: profit +41.2% vs revenue +85.6%. Profit is growing slower than sales — costs are eating the growth before it reaches the bottom line.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years 81% of Ashapura Minechem Ltd's reported profit arrived as operating cash — the cash follows the profit. In FY26 that was ₹463 Cr of operating cash against ₹416 Cr of profit. After ₹279 Cr of capital spending, ₹184 Cr was left as free cash.
FY26: operating cash of ₹463 Cr against reported profit of ₹416 Cr, leaving free cash of ₹184 Cr after ₹279 Cr of capital spending. Across the last 3 fiscal years the conversion rate is 81% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
Why conversion sits at 81%: the cash cycle tightened 17 days between FY21 and FY26 — cash that used to wait in the cycle now reaches the bank sooner.
Router verdict: the bigger cash user is investment — capital spending ran 3.4× depreciation over three years, so the next section's job is to check what that build-out is buying.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
Ashapura Minechem Ltd's cash conversion cycle runs −22 days in FY26, down from −5 days in FY21. Capital spending ran ₹994 Cr over the last 3 years. At FY26 sales of ₹5,237 Cr each day of that cycle holds about ₹14.3 Cr, so roughly ₹−316 Cr sits inside the business at any moment.
FY26: debtors at 70 days, inventory at 153 days — roughly 5.0 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of −22 days, tighter than FY21's −5.
The full loop: cash goes out to suppliers and production on day 0; stock waits 153 days to sell; customers pay about 70 days after that; and suppliers themselves are paid at 245 days — netting out to the −22-day cycle.
In money terms: at FY26 sales of ₹5,237 Cr, each day of the cycle holds about ₹14.3 Cr — so the −22-day loop keeps roughly ₹−316 Cr sitting inside the business at any moment.
On the investment side: capital spending of ₹994 Cr over the last 3 fiscal years against ₹290 Cr of depreciation — the company is building well ahead of wear-and-tear. Capital work-in-progress stands at ₹51.0 Cr (FY26) — capacity paid for but not yet earning.
The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.
Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.
Ashapura Minechem Ltd earns a ROCE of 21% in FY26. That is up from a trough of −42% in FY19. A return-on-invested-capital spread against the cost of capital is not computable from what is held here. The wiring behind it is 7.9% net margin on 1.11× asset turns.
FY26 ROCE is 21%, recovered from a FY19 trough of −42% — the full ladder below shows the fall and the climb, undoctored.
Why the return is what it is — the wiring (FY26): 7.9% net margin × 1.11× asset turns × 2.85× balance-sheet leverage ≈ 25.0% on equity. Margin does its share; leverage is a meaningful part of the equation.
The quarterly return curves and the return-on-invested-capital overlay, which only the second data source carries, are not drawn on this page: its two data sources disagree by up to 16% on reported income across 14 comparable periods. A figure two sources cannot agree on is not drawn — the gap is a decision, not missing data.
Debt Debt-to-equity says how much of the business is funded by borrowings; interest cover says how many times operating profit pays the interest bill. Low and high, respectively, is the safe corner.
Ashapura Minechem Ltd carries ₹1,444 Cr of borrowings against ₹1,649 Cr of equity in FY26, a debt-to-equity of 0.88. Operating profit covers the interest bill 5×. Over 5 years borrowings went from ₹664 Cr to ₹1,444 Cr. Capital spending ran ₹994 Cr across the last 3 of those years.
FY26: borrowings of ₹1,444 Cr against equity of ₹1,649 Cr — a debt-to-equity of 0.88. Operating profit covers the interest bill 5×. Over 5 years borrowings went from ₹664 Cr to ₹1,444 Cr while capital spending ran ₹994 Cr in just the last 3 — part of the build-out is riding on borrowed money.
The total-debt and debt-to-equity series, which only the second data source carries, are not drawn on this page: its two data sources disagree by up to 16% on reported income across 14 comparable periods. A figure two sources cannot agree on is not drawn — the gap is a decision, not missing data.
Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.
Foreign institutions added 2.8 points of Ashapura Minechem Ltd over 8 quarters, the biggest move on the register. That takes foreign institutions to 19.2% of the company. Promoters moved +2.6 points over the same window, to 48.0%. The register is read on the four disclosed classes only; nothing is inferred between filings.
The register over the last two years — Foreign institutions: +2.8 points over 8 quarters to 19.2%; Promoters: +2.6 points over 8 quarters to 48.0%; Domestic institutions: +0.0 points over 8 quarters to 0.4%.
Why the register moved: foreign institutions drove it (+2.8 points), alongside promoters (+2.6 points) — steady accumulation by institutions reading the same numbers this page reads.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Ashapura Minechem Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.
The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1South West Pinnacle Exploration LtdSOUTHWEST | 73.2/100Favorable setup87% evidence | ASLEEP | 30.3/35 Revenue 39.2% · PAT 100% · OPM change 9.8 pp 95% evidence | 19.0/25 ROCE 20% · OPM 24.2% 95% evidence | 12.0/20 P/E 17.4× · PEG — 50% evidence | 11.9/20 RS sector 1.9% · RS bench 6.1% · 1Y 48.2%0 of 12 weeks ahead 100% evidence |
| Exact sum: 30.3 + 19 + 12 + 11.9 = 73.2 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence. | ||||||
| 2Vedanta LtdVEDL | 57.0/100Mixed-positive evidence82% evidence | ASLEEP | 20.2/35 Revenue 2% · PAT 43.5% · OPM change 8 pp 95% evidence | 15.4/25 ROCE 16.1% · OPM 35% 76% evidence | 8.7/20 P/E 9.4× · PEG — 50% evidence | 12.7/20 RS sector 4.5% · RS bench 8.6% · 1Y 63.6%2 of 12 weeks ahead 100% evidence |
| Exact sum: 20.2 + 15.4 + 8.7 + 12.7 = 57 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 3Ashapura Minechem Ltdthis pageASHAPURMIN | 55.1/100Mixed-positive evidence76% evidence | ASLEEP | 20.2/35 Revenue 62.6% · PAT 19.5% · OPM change -2 pp 95% evidence | 18.0/25 ROCE 20.7% · OPM 11% 76% evidence | 11.5/20 P/E 12.6× · PEG — 50% evidence | 5.4/20 RS sector -20.6% · RS bench -15.8% · 1Y -3.4%4 of 10 weeks ahead 70% evidence |
| Exact sum: 20.2 + 18 + 11.5 + 5.4 = 55.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 4Indian Metals & Ferro Alloys LtdIMFA | 55.0/100Mixed-positive evidence100% evidence | ASLEEP | 22.5/35 Revenue 23.6% · PAT 46.6% · OPM change 9 pp 100% evidence | 16.4/25 ROCE 18.4% · OPM 29% 100% evidence | 9.9/20 P/E 12.8× · PEG 1.4 100% evidence | 6.2/20 RS sector -9.5% · RS bench -5.1% · 1Y 27.4%0 of 12 weeks ahead 100% evidence |
| Exact sum: 22.5 + 16.4 + 9.9 + 6.2 = 55 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 5Coal India LtdCOALINDIA | 53.1/100Mixed-positive evidence82% evidence | ASLEEP | 6.8/35 Revenue 6.1% · PAT -5.9% · OPM change -3 pp 95% evidence | 20.7/25 ROCE 35% · OPM 26% 76% evidence | 11.3/20 P/E 8.4× · PEG — 50% evidence | 14.3/20 RS sector -2.7% · RS bench 2.1% · 1Y 8.6%0 of 12 weeks ahead 100% evidence |
| Exact sum: 6.8 + 20.7 + 11.3 + 14.3 = 53.1 · Decision use: Price leads the evidence: RS versus the benchmark is 2.1%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 6Deccan Gold Mines LtdDECNGOLD | 51.1/100Thin evidence · provisional54% evidence | BREAKING OUT | 26.2/35 Revenue 100% · PAT 58.7% · OPM change 4414.3 pp 71% evidence | 5.3/25 ROCE -13.1% · OPM — 61% evidence | 10.0/20 P/E — · PEG — 0% evidence | 9.6/20 RS sector -23% · RS bench 63.1% · 1Y 86.6%10 of 10 weeks ahead 70% evidence |
| Exact sum: 26.2 + 5.3 + 10 + 9.6 = 51.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 720 Microns Ltd20MICRONS | 50.3/100Mixed-positive evidence81% evidence | BREAKING OUT | 13.1/35 Revenue 2.5% · PAT 11.5% · OPM change 0 pp 95% evidence | 17.6/25 ROCE 17.3% · OPM 13% 95% evidence | 11.9/20 P/E 10.8× · PEG — 50% evidence | 7.7/20 RS sector -40.9% · RS bench 10.3% · 1Y -10.2%9 of 10 weeks ahead 70% evidence |
| Exact sum: 13.1 + 17.6 + 11.9 + 7.7 = 50.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 8Midwest Energy Ltd526570 | 49.3/100Thin evidence · provisional58% evidence | ASLEEP | 22.3/35 Revenue 100% · PAT -80% · OPM change 547.7 pp 71% evidence | 4.1/25 ROCE -2.5% · OPM -7.4% 76% evidence | 10.0/20 P/E — · PEG — 0% evidence | 12.9/20 RS sector 97.8% · RS bench -7.6% · 1Y 77.9%0 of 10 weeks ahead 70% evidence |
| Exact sum: 22.3 + 4.1 + 10 + 12.9 = 49.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 9MOIL LtdMOIL | 46.1/100Mixed-negative evidence100% evidence | ASLEEP | 12.9/35 Revenue 4.9% · PAT 7.8% · OPM change 14 pp 100% evidence | 13.1/25 ROCE 12.4% · OPM 37% 100% evidence | 14.4/20 P/E 16.4× · PEG 0.68 100% evidence | 5.7/20 RS sector -25.3% · RS bench -20.8% · 1Y -30.4%0 of 12 weeks ahead 100% evidence |
| Exact sum: 12.9 + 13.1 + 14.4 + 5.7 = 46.1 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 10KIOCL LtdKIOCL | 43.0/100Mixed-negative evidence68% evidence | ASLEEP | 24.0/35 Revenue 27.5% · PAT 100% · OPM change 29 pp 74% evidence | 3.7/25 ROCE 1.4% · OPM -17% 100% evidence | 8.5/20 P/E 556× · PEG — 15% evidence | 6.8/20 RS sector -15.2% · RS bench -5.8% · 1Y -21.2%1 of 10 weeks ahead 70% evidence |
| Exact sum: 24 + 3.7 + 8.5 + 6.8 = 43 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -15.2% and the one-year return is -21.2%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 11Gujarat Mineral Development Corporation LtdGMDCLTD | 41.2/100Mixed-negative evidence100% evidence | ASLEEP | 13.4/35 Revenue 2.3% · PAT 43.5% · OPM change -2 pp 100% evidence | 10.8/25 ROCE 10.8% · OPM 21% 100% evidence | 7.6/20 P/E 32.1× · PEG 1.28 100% evidence | 9.4/20 RS sector -5.9% · RS bench -1.2% · 1Y 13%0 of 12 weeks ahead 100% evidence |
| Exact sum: 13.4 + 10.8 + 7.6 + 9.4 = 41.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 12Orissa Minerals Development Company LtdORISSAMINE | 39.0/100Thin evidence · provisional59% evidence | ASLEEP | 17.1/35 Revenue 45.7% · PAT 92.8% · OPM change 511.5 pp 62% evidence | 7.8/25 ROCE 9.6% · OPM -32.2% 95% evidence | 10.0/20 P/E — · PEG — 0% evidence | 4.1/20 RS sector -39.8% · RS bench -9.1% · 1Y -18.2%4 of 10 weeks ahead 70% evidence |
| Exact sum: 17.1 + 7.8 + 10 + 4.1 = 39 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 13Bharat Coking Coal LtdBHARATCOAL | 37.2/100Thin evidence · provisional35% evidence | ASLEEP | 10.7/35 Revenue — · PAT — · OPM change -6.8 pp 45% evidence | 6.5/25 ROCE 4% · OPM -1.8% 76% evidence | 10.0/20 P/E — · PEG — 0% evidence | 10.0/20 RS sector — · RS bench — · 1Y —3 of 12 weeks ahead 0% evidence |
| Exact sum: 10.7 + 6.5 + 10 + 10 = 37.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is Ashapura Minechem Ltd's share price today?
Ashapura Minechem Ltd trades at ₹543, −10.7% over the past year. The company is valued at ₹5,186 Cr. The stock sits at 13% of its 52-week range of ₹487–₹901, −13.0% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 16 weeks in. — as of 11 September 2026.
What were Ashapura Minechem Ltd's latest quarterly results?
Ashapura Minechem Ltd reported revenue of ₹1,616 Cr and net profit of ₹108 Cr for the Jun 26 quarter. Revenue rose 19.2% and profit fell 5.3% year on year. Earnings per share were ₹12.07. The operating margin was 11.0%, 2.0 pp lower than a year earlier. — as of 11 September 2026.
What is Ashapura Minechem Ltd's revenue?
Ashapura Minechem Ltd reported revenue of ₹1,616 Cr in the Jun 26 quarter, +19.2% year on year. For the full FY26 fiscal year, revenue was ₹5,237 Cr (+91.2%). Over the last 10 years revenue compounded at 11.4% a year. — as of 11 September 2026.
What is Ashapura Minechem Ltd's profit?
Ashapura Minechem Ltd earned ₹108 Cr of net profit in the Jun 26 quarter, −5.3% year on year. Full-year FY26 profit was ₹416 Cr. The operating margin ran 11.0% in the latest quarter. — as of 11 September 2026.
What is Ashapura Minechem Ltd's market cap?
Ashapura Minechem Ltd's market capitalisation is ₹5,186 Cr at a share price of ₹543. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 11 September 2026.
What is Ashapura Minechem Ltd's P/E ratio?
Ashapura Minechem Ltd trades at a P/E of 12.6×, at the 37th percentile of its own 11-year range, against a long-run median of 14.2×. This is a comparison with the stock's own history, not a value call — as of 11 September 2026.
Does Ashapura Minechem Ltd pay a dividend?
Yes — Ashapura Minechem Ltd's dividend payout was 5% of profit in FY26, and it recorded a payout in 4 of its last 13 reported fiscal years. This page holds the payout ratio, not a per-share amount. — as of 11 September 2026.
Is Ashapura Minechem Ltd overvalued?
On its own history, Ashapura Minechem Ltd looks mid-range: its P/E of 12.6× sits at the 37th percentile of its 11-year range (long-run median 14.2×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 11 September 2026.
Is Ashapura Minechem Ltd growing?
Not right now — Ashapura Minechem Ltd's latest numbers are shrinking: latest-quarter revenue +19.2% year on year, profit −5.3%, and the margin −2.0 pp at 11.0%. The 10-year compound rates are 11.4% (revenue) and 9.9% (profit). The earnings engine currently reads: deteriorating — as of 11 September 2026.
How is Ashapura Minechem Ltd performing?
Ashapura Minechem Ltd is in a confirmed uptrend, 16 weeks in. Its latest quarter's revenue rose 19.2% and profit fell 5.3% year on year. Against the NIFTY 500 it has been behind on a trailing-13-week view for 11 weeks. This describes what the data did, not a rating. — as of 11 September 2026.
What stage is Ashapura Minechem Ltd in?
Mixed — growth is normalizing off a hyper-growth base: profit growth has eased from +43.9% at its peak to +19.5% but is still expanding, ROCE lifting at 21.0%. The read comes from the last 12 quarters of growth (revenue growth +62.6% latest, profit growth +19.5% latest, eps growth +17.6% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 11 September 2026.
Is Ashapura Minechem Ltd in an uptrend?
Yes — the price is in a confirmed uptrend (week 16 of stage 2), trading −13.0% versus its 200-day average and at 13% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 11 September 2026.
Is Ashapura Minechem Ltd beating the market?
Not lately — on a trailing-13-week view Ashapura Minechem Ltd is currently behind the NIFTY 500 (11 weeks and counting; last ahead the week of 2026-07-01), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.5 years the stock moved +594% against the NIFTY 500's +267% — ahead of the index over the full window. — as of 11 September 2026.
Will Ashapura Minechem Ltd's share price go up?
This page publishes no price forecast for Ashapura Minechem Ltd. What it measures instead: the share price is ₹543, the price is in a confirmed uptrend 16 weeks in. Its P/E of 12.6× sits at the 37th percentile of its own 11-year range. — as of 11 September 2026.
Who owns Ashapura Minechem Ltd?
Promoters hold 48.0% of Ashapura Minechem Ltd, foreign institutions 19.2%, domestic institutions 0.4% and the public 32.3% (latest quarter). The biggest move on the register over the last two years: Foreign institutions added 2.8 points over 8 quarters. — as of 11 September 2026.
Does Ashapura Minechem Ltd have too much debt?
It is moderate — Ashapura Minechem Ltd's debt-to-equity is 0.88, and operating profit covers the interest bill 5×. FY26 borrowings were ₹1,444 Cr against equity of ₹1,649 Cr. Read the returns on this page with that leverage in mind — as of 11 September 2026.
What is Ashapura Minechem Ltd's capex?
Ashapura Minechem Ltd spent ₹994 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was ₹279 Cr, with ₹51.0 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 11 September 2026.
What is Ashapura Minechem Ltd's cash flow?
Ashapura Minechem Ltd generated ₹463 Cr of operating cash flow in FY26 and ₹184 Cr of free cash flow after ₹279 Cr of capital spending. Reported profit that year was ₹416 Cr, so operating cash ran ahead of profit. Cash-flow resolution for India is annual. — as of 11 September 2026.
Is Ashapura Minechem Ltd's profit real cash?
Yes — over the last 3 fiscal years, 81% of Ashapura Minechem Ltd's reported profit arrived as operating cash. In FY26, operating cash was ₹463 Cr against reported profit of ₹416 Cr. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 11 September 2026.
Where is Ashapura Minechem Ltd in its business cycle?
Ashapura Minechem Ltd's FY26 operating margin was 11.0%, against a 13-year band of −14.0%–22.0%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran 11.0%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 11 September 2026.
What growth does Ashapura Minechem Ltd's price assume?
At its price on 13 June 2026, Ashapura Minechem Ltd was priced for profit growth of about 6.3% a year. Profit itself has compounded 9.9% a year over the past 10 years. The figure reads the multiple backwards: the growth a buyer at that price was already paying for. — as of 11 September 2026.
What could break the Ashapura Minechem Ltd story?
The sharpest disagreement: annual EPS moved +35.7% against a −10.7% price move — the market has not yet caught up with the delivery. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 11 September 2026.
Is Ashapura Minechem Ltd a stock worth studying right now?
This is not investment advice. The machine read: Ashapura Minechem Ltd's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it. The sharpest open question: whether the price catches up with earnings that have already moved. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 11 September 2026.
Not SEBI Registered !! Not Investment advice !!